Fig. 8
From: SLC39A1 contribute to malignant progression and have clinical prognostic impact in gliomas
Effect of SLC39A1 on MMP2/MMP9 in glioma. a, b The expression of SLC39A1 mRNA (a) and protein (b) in different groups. c, d The expression of MMP2/MMP9 mRNA (c) and protein (d) in different groups. Con, negative control group; overexpression, SLC39A1 overexpression group; NC, plasmid control group; siRNA, SLC39A1 knockdown groups; si-NC, negative control siRNA. *P<0.05